GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » EV-to-FCF

Suzhou Basecare Medical (HKSE:02170) EV-to-FCF : 0.45 (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Suzhou Basecare Medical's Enterprise Value is HK$-181.1 Mil. Suzhou Basecare Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-406.3 Mil. Therefore, Suzhou Basecare Medical's EV-to-FCF for today is 0.45.

The historical rank and industry rank for Suzhou Basecare Medical's EV-to-FCF or its related term are showing as below:

HKSE:02170' s EV-to-FCF Range Over the Past 10 Years
Min: -100.97   Med: 0.45   Max: 3.81
Current: 0.44

During the past 6 years, the highest EV-to-FCF of Suzhou Basecare Medical was 3.81. The lowest was -100.97. And the median was 0.45.

HKSE:02170's EV-to-FCF is ranked better than
93.82% of 356 companies
in the Medical Devices & Instruments industry
Industry Median: 26.755 vs HKSE:02170: 0.44

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-21), Suzhou Basecare Medical's stock price is HK$1.96. Suzhou Basecare Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.766. Therefore, Suzhou Basecare Medical's PE Ratio for today is At Loss.


Suzhou Basecare Medical EV-to-FCF Historical Data

The historical data trend for Suzhou Basecare Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical EV-to-FCF Chart

Suzhou Basecare Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - -0.09 1.08 0.20

Suzhou Basecare Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 - 1.08 - 0.20

Competitive Comparison of Suzhou Basecare Medical's EV-to-FCF

For the Medical Devices subindustry, Suzhou Basecare Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Basecare Medical's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's EV-to-FCF falls into.



Suzhou Basecare Medical EV-to-FCF Calculation

Suzhou Basecare Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-181.052/-406.275
=0.45

Suzhou Basecare Medical's current Enterprise Value is HK$-181.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Suzhou Basecare Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-406.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzhou Basecare Medical  (HKSE:02170) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Suzhou Basecare Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.96/-0.766
=At Loss

Suzhou Basecare Medical's share price for today is HK$1.96.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Suzhou Basecare Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.766.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Suzhou Basecare Medical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Basecare Medical (HKSE:02170) Business Description

Traded in Other Exchanges
N/A
Address
BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.
Executives
Orbimed Capital Llc 2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited 2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited 2101 Beneficial owner
Dawn Capital Fund 2101 Beneficial owner
Dawn Capital Limited 2102 Investment manager
Hh Spr-xiv Cy Holdings Limited 2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited 2101 Beneficial owner
Hh Spr-xiv Holdings L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd. 2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines